niel
c
pedersen
dvm
histor
f
elin
infecti
periton
fip
first
describ
import
disord
cat
holzworth
angel
memori
anim
hospit
boston
clinicopatholog
confer
disord
publish
follow
year
diseas
thought
infecti
specif
etiolog
agent
identifi
time
wolf
griesem
first
propos
fip
caus
viru
zook
et
al
observ
viru
particl
tissu
experiment
infect
cat
unabl
character
agent
ward
recogn
close
similar
fip
viru
fipv
tissu
member
famili
coronavirida
montali
strandberg
first
report
fipv
infect
could
either
granulomat
dri
parenchymat
effus
wet
nonparenchymat
close
genet
relationship
fipv
coronavirus
dog
swine
first
report
pedersen
et
al
fulli
virul
fipv
first
propag
vitro
autochthon
macrophag
cultur
experiment
infect
cat
later
tissu
cultur
also
replic
epithelium
intestin
ring
cultur
strain
fipv
first
propag
continu
passsag
feli
catu
whole
cell
shown
virul
inocul
cat
cell
later
found
macrophag
type
exist
two
serotyp
felin
coronaviru
fcov
like
canin
coronaviru
ccv
like
felin
coronavirus
first
report
sudden
appear
fip
late
document
longterm
meticul
necropsi
record
angel
memori
anim
hospit
boston
therefor
exist
signific
diseas
entiti
prior
time
question
refer
cat
diseas
resembl
fip
publish
half
centuri
earlier
jakob
quot
de
groot
horzinek
whether
fip
uncertain
given
absenc
report
similar
condit
interven
decad
steadi
increas
incid
diseas
onward
current
one
lead
infecti
caus
death
among
young
cat
shelter
catteri
reason
sudden
emerg
fip
known
least
three
possibl
explan
first
coronavirus
may
speciat
cat
within
last
half
centuri
noteworthi
fip
appear
within
decad
initi
descript
transmiss
gastroenter
tge
pig
north
america
caus
viru
fip
close
relat
tge
viru
pig
ccv
although
still
genet
distinguish
howev
recombin
three
virus
known
occur
least
one
strain
ccv
induc
mild
enter
cat
enhanc
subsequ
infect
fipv
indic
special
close
felin
coronavirus
therefor
ccv
may
like
parent
fecv
scenario
recombin
event
favor
eas
transcript
unit
rna
gain
lost
diverg
evolut
coronavirus
secondli
fip
mutat
may
select
variant
fecv
appear
variant
could
also
arisen
intraand
interspeci
mutabl
coronavirus
gener
case
fcov
particular
third
explan
may
involv
chang
cat
view
pet
husbandri
modern
era
dramat
shift
statu
keep
breed
cat
pet
world
war
ii
number
pet
cat
greatli
increas
purebreed
catteri
rear
becam
increasingli
popular
cat
particular
kitten
found
shelter
larg
multipl
cat
indoor
environ
known
favor
felin
enter
coronaviru
fecv
infect
fip
review
pedersen
et
al
interestingli
felin
leukemia
viru
felv
infect
also
becam
rampant
among
indoor
multicat
household
period
felv
infect
signific
cofactor
fip
push
back
natur
test
eliminationisol
eventu
vaccin
caus
agent
fipv
virul
form
biotyp
fecv
gener
name
fcov
loos
appli
serotyp
biotyp
felin
coronavirus
use
nomenclatur
fecv
technic
enter
biotyp
fcov
fipv
fip
biotyp
unfortun
widespread
use
gener
term
fcov
led
confus
review
world
literatur
often
difficult
sometim
imposs
determin
viru
biotyp
discuss
even
studi
avoid
confus
review
attempt
deciph
variou
author
mean
gener
term
fcov
use
use
fecv
refer
ubiquit
enter
biotyp
fcov
present
healthi
cat
popul
fipv
referenc
virul
biotyp
caus
fip
individu
cat
fipv
somewhat
uniqu
virus
infrequ
spread
anim
anim
horizont
manner
yet
highli
infecti
extract
affect
tissu
fluid
inocul
cat
number
rout
see
discuss
experiment
infect
regard
fipv
resembl
infecti
acut
sarcomainduc
retrovirus
cat
mutant
form
found
tumor
horizont
transmit
natur
parent
felv
shed
variou
excret
secret
horizont
spread
therefor
fipv
strongli
cell
tissu
bound
shed
fece
urin
would
possibl
special
circumst
lesion
effac
renal
collect
duct
intestin
wall
shed
urin
fece
infect
urin
report
least
literatur
genom
structur
felin
coronavirus
similar
genom
incorpor
singl
rna
strand
made
around
nucleotid
put
open
read
frame
orf
gene
includ
nonstructur
replicas
two
larg
orf
four
structur
orf
encod
spike
envelop
membran
nucleocapsid
protein
five
accessori
orf
b
gene
essenti
virul
base
identif
field
strain
fecv
fipv
lack
function
gene
likewis
small
delet
mutat
gene
found
isol
associ
enter
infect
fip
howev
function
mutat
gene
mention
fipv
like
fecv
also
exist
two
serotyp
base
viru
neutral
antibodi
type
type
ii
serotyp
viru
distinct
felin
spike
protein
spike
protein
type
ii
serotyp
recombin
felin
canin
enter
coronavirus
type
fecvsfipv
predomin
throughout
world
type
ii
strain
make
isol
certain
countri
japan
type
ii
strain
appear
adapt
tissu
cultur
howev
type
strain
may
like
caus
clinic
fip
addit
two
serotyp
fecv
fipv
biotyp
exist
numer
strain
defin
distinct
singl
nucleotid
polymorph
snp
insertiondelet
indel
differ
small
isol
within
group
cat
seldom
isol
geograph
distinct
region
mutat
found
gene
extent
tend
concentr
nine
accessori
structur
gene
rather
two
gene
compris
larg
replicas
function
mutat
sever
accessori
gene
includ
appear
prevent
replic
either
vitro
vivo
evid
certain
strain
fecv
like
mutat
fipv
need
thoroughli
studi
mutat
respons
fipv
biotyp
consist
found
gene
encod
small
protein
unknown
function
nc
pedersen
uc
davi
manuscript
submit
mutat
usual
snp
caus
prematur
stop
codon
delet
mutat
negat
significantli
truncat
gene
product
specif
deleteri
mutat
orf
differ
even
affect
kitten
litter
nc
pedersen
uc
davi
manuscript
submit
support
intern
mutat
autoinfect
rather
cattocat
transmiss
primari
rout
exposur
loss
gene
function
prevent
replic
vivo
vitro
thought
drastic
alter
cell
tropism
enhanc
intern
replic
fipv
macrophag
contrast
parent
fecv
tropic
matur
apic
epithelium
bowel
howev
may
simplist
fecv
infect
system
well
intestin
phase
may
present
monocyt
phagocyt
rich
organ
primari
infect
question
howev
extent
fecv
replic
nonintestin
cell
organ
fecv
fipv
mutat
like
occur
primari
infect
kitten
condit
lead
higher
level
fecv
replic
latter
decreas
resist
mutat
occur
fipv
mutant
occur
primari
fecvinfect
cat
one
studi
howev
fecv
infect
often
recurr
evid
fip
may
also
occur
consequ
recurr
bout
viru
replic
addi
et
al
follow
cat
deem
recurr
fecv
infect
base
decreas
rise
antibodi
titer
anim
subsequ
develop
fip
intern
mutat
theori
fecv
fipv
convers
recent
question
dye
siddel
compar
full
length
genom
sequenc
virus
found
two
differ
tissu
cat
classic
fip
studi
base
earlier
find
addi
et
al
show
mani
cat
fip
shed
coronaviru
presum
fecv
fece
fipv
lesion
tissu
liver
put
fecv
obtain
segment
jejunum
found
differ
sequenc
two
virus
suggest
call
intern
mutat
theori
question
howev
sequenc
viral
genom
present
two
tissu
show
extens
mutat
region
occur
fipv
true
fecv
jejunum
known
site
fecv
replic
acut
infect
ileum
colon
rectum
furthermor
recent
document
portion
coronavirus
isol
fece
cat
fipv
much
like
resembl
fipv
tissu
parent
fecv
mean
fecal
coronavirus
intact
gene
design
fecv
therefor
two
virus
compar
dye
siddel
ident
fipv
sever
studi
impli
whether
cat
develop
fip
fecv
exposur
determin
host
respond
viru
differ
biotyp
anoth
studi
suggest
fip
result
system
spread
fecv
gut
blood
monocyt
howev
doubt
fecv
fipv
genet
distinct
minor
crucial
manner
differ
essenti
caus
fip
furthermor
immun
fecv
infect
confer
immun
fipv
infect
differ
immun
two
virus
qualit
mere
quantit
howev
host
environment
factor
admittedli
play
role
whether
fip
clinic
manifest
epizootiolog
fip
mainli
diseas
domest
cat
also
recogn
african
lion
mountain
lion
leopard
cheetah
jaguar
lynx
serval
carac
european
wild
cat
sand
cat
palla
cat
almost
ident
infecti
periton
describ
interferongamma
defici
mice
ferret
infect
respect
speci
coronaviru
fip
occur
wherev
fecv
found
therefor
worldwid
ubiquit
among
virtual
cat
popul
thu
epizootiolog
fip
close
link
fecv
shed
fecv
transient
recurr
chronic
period
month
year
fecv
present
virtual
catteri
shelter
six
cat
shed
pet
cat
multicat
household
onethird
older
cat
kitten
juvenil
present
shelter
sacramento
ca
usa
shed
fecv
time
entri
signific
proport
cat
feral
popul
fair
say
fecv
enzoot
among
indoor
outdoor
cat
popul
similar
find
report
countri
bell
et
al
found
seropreval
fecv
among
pedigre
cat
sydney
area
nonexist
feral
cat
test
confirm
number
cat
per
household
signific
influenc
infect
rate
certain
breed
higher
incid
seroposit
other
extens
studi
undertaken
natur
experiment
fecv
infect
infect
spread
fecaleor
rout
viral
shed
fece
occur
within
week
exposur
shed
occur
ileum
colon
rectum
shed
fecv
persist
month
persist
month
intermitt
month
thereaft
clear
within
month
studi
review
pedersen
et
al
howev
immun
recov
cat
tenuou
reinfect
resembl
primari
exposur
often
occur
strain
tend
persist
cat
within
given
catteri
region
howev
occasion
cat
group
may
infect
one
strain
differ
strain
viru
shed
somewhat
associ
coronaviru
antibodi
titer
level
group
cat
indirect
fluoresc
antibodi
titer
much
like
coronaviru
shedder
group
cat
titer
death
fip
occur
cat
month
age
uncommon
year
one
studi
fip
common
singl
caus
diseas
cat
younger
year
age
cancer
common
singl
disord
year
age
rang
incid
fip
veterinari
medic
teach
hospit
among
new
felin
visit
among
total
cat
access
access
diagnost
laboratori
incid
fip
significantli
higher
among
kitten
younger
cat
origin
purebre
catteri
shelter
averag
young
catteri
shelter
cat
us
die
fip
lose
catteri
higher
shelter
enzoot
mortal
note
least
year
among
young
cat
kitten
origin
four
typic
catteri
studi
cave
et
al
studi
caus
death
among
shelter
privat
own
pedigre
nonpedigre
kitten
twentyf
percent
kitten
mortal
due
felin
parvoviru
fpv
main
viral
infect
dayold
felin
herpesviru
felin
caliciviru
fip
caus
death
kitten
postwean
day
age
period
incid
fip
loss
occur
enzoot
epizoot
former
common
fip
loss
sporad
unpredict
infrequ
enzoot
form
catteri
enzoot
fip
may
death
year
follow
sever
case
rapid
success
diseas
may
disappear
reappear
month
year
later
overal
mortal
enzoot
diseas
longer
period
usual
howev
epizoot
observ
group
kitten
rais
one
catteri
period
similar
explos
outbreak
seen
sever
catteri
epizoot
fip
seldom
last
month
return
enzoot
state
enzoot
fip
usual
associ
persist
similar
strain
enter
coronavirus
within
popul
epizoot
multifactori
reflect
increas
popul
stress
usual
associ
overcrowd
high
kitten
product
unintent
use
genet
predispos
breed
stock
possibl
bout
horizont
transmiss
introduct
new
strain
fecv
sever
risk
factor
fip
identifi
catteri
studi
fip
significantli
associ
particular
catteri
mean
cat
number
mean
age
gender
catteri
median
coronaviru
antibodi
titer
husbandri
quarantin
practic
cage
breed
practic
preval
concurr
diseas
howev
individu
cat
age
individu
cat
coronaviru
titer
overal
frequenc
fecal
coronarviru
shed
proport
cat
catteri
chronic
fecv
shedder
associ
increas
risk
fip
death
fip
frequent
fall
winter
basi
analysi
catteri
record
number
death
vari
yearli
epizoot
mortal
rate
report
least
year
among
four
catteri
studi
one
signific
factor
appear
genet
suscept
account
incid
multicat
household
person
experienc
fip
lose
reloc
sold
cat
later
develop
fip
like
experi
fip
period
household
experienc
prior
fip
lose
catteri
lost
cat
fip
thu
everi
catteri
enzoot
fecv
infect
risk
lose
cat
fip
breed
enough
kitten
long
enough
time
risk
develop
fip
appear
decreas
period
year
group
cat
indic
increas
popul
resist
incid
fip
shelter
seem
directli
correl
number
densiti
young
cat
length
time
held
adopt
greater
longer
much
wors
k
hurley
uc
davi
unpublish
find
report
us
europ
indic
increas
risk
young
cat
purebr
intact
male
decreas
risk
spay
femal
report
confirm
fip
case
australia
shown
fip
overrepres
certain
pure
breed
burmes
australian
mist
british
shorthair
cornish
rex
underrepres
breed
domest
shorthair
persian
even
distribut
across
age
spectrum
breed
incid
anoth
veterinari
teach
hospit
analyz
period
breed
gender
reproduct
statu
affect
cat
compar
gener
cat
popul
mix
breed
cat
evalu
period
previou
studi
sexual
intact
cat
purebre
cat
significantli
like
diagnos
fip
male
young
cat
also
higher
preval
diseas
abyssinian
bengal
birman
himalayan
ragdol
rex
significantli
higher
risk
wherea
burmes
exot
shorthair
manx
persian
russian
blue
siames
cat
decreas
risk
studi
indic
incid
fip
among
breed
vari
greatli
countri
region
fip
lose
probabl
relat
bloodlin
within
breed
breed
fip
refer
common
effus
wet
nonparenchymat
form
diseas
transmiss
inflammatori
condit
viscer
serosa
omentum
exud
abdomen
second
form
diseas
character
granulomat
involv
parenchymat
organ
kidney
mesenter
lymph
node
bowel
wall
liver
central
nervou
system
cn
eye
granulomat
fip
call
dri
parenchymat
noneffus
inflammatori
exud
bodi
caviti
common
form
fip
wet
effus
although
proport
cat
dri
fip
appear
rise
last
decad
cat
rare
manifest
form
diseas
time
usual
transit
stage
wet
dri
dri
wet
experiment
condit
cat
develop
dri
fip
often
brief
episod
effus
diseas
onset
cat
dri
fip
may
becom
effus
termin
stage
ill
howev
transit
much
less
notic
natur
incub
period
time
infect
diseas
effus
fip
day
experiment
condit
incub
period
experiment
induc
dri
fip
sever
week
longer
howev
actual
incub
period
natur
infect
unknown
evid
infect
may
smolder
subclin
state
week
month
even
year
overt
sign
notic
retrospect
clinic
onset
fip
may
preced
long
histori
vagu
ill
health
stunt
growth
coinfect
felin
pathogen
may
lower
resist
fipv
may
complic
diseas
pictur
see
preced
discuss
earliest
sign
overt
fip
besid
failur
thrive
young
cat
includ
progress
worsen
malais
fluctuat
fever
inappet
weight
loss
sign
diseas
superimpos
basic
diseas
sign
depend
form
organ
distribut
inflamm
tabl
abdomin
distens
common
physic
find
wet
fip
rank
higher
cardiovascular
diseas
neoplasia
hepat
renal
diseas
caus
ascit
cat
fig
abdomen
besid
greatli
enlarg
often
doughi
feel
painless
palpat
fluid
wave
easili
induc
percuss
upon
open
abdomen
found
contain
liter
yellowting
slight
moder
cloudi
mucin
fluid
fig
dyspnea
featur
cat
pleural
involv
thorac
effus
tabl
clinic
sign
due
ocular
cn
involv
seen
less
cat
wet
form
fip
tabl
sever
uncommon
featur
effus
fip
warrant
mention
intact
male
frequent
develop
scrotal
enlarg
due
extens
periton
tunic
surround
test
edema
fig
syndrom
hepat
lipidosi
extrem
skin
fragil
describ
one
cat
wet
fip
inutero
fipv
infect
observ
kitten
born
queen
develop
effus
fip
pregnanc
pneumonia
pleuriti
hepat
princip
lesion
affect
kitten
mani
cat
fip
gener
synov
due
immun
complex
migrat
infect
macrophagemonocyt
synovium
cat
fip
may
present
therefor
sign
fever
lame
mistaken
anoth
type
infect
immunemedi
polyarthr
howev
classic
sign
fip
usual
develop
soon
make
caus
lame
appar
ml
yellow
mucin
effus
remov
abdomen
necropsi
note
fibrin
tag
liver
spleen
ground
glass
appear
serosa
name
dri
fip
impli
thorac
abdomin
effus
either
absent
scant
detect
necropsi
involv
eye
andor
cn
predomin
cat
dri
fip
tabl
sign
refer
abdomin
involv
seen
anim
either
without
ocular
cn
diseas
tabl
abdomin
lesion
dri
fip
much
larger
fewer
number
less
widespread
lesion
wet
fip
lesion
dri
fip
tend
extend
downward
seros
pleural
surfac
underli
parenchyma
henc
altern
name
parenchymat
fip
abdomin
lesion
frequent
found
kidney
fig
mesenter
lymph
node
fig
somewhat
less
frequent
liver
hepat
lymph
node
fig
involv
wall
caecum
colon
associ
caecocol
lymphadenopathi
specif
form
dri
fip
fig
associ
sign
typic
ulcer
coliti
ie
soft
blood
mucu
laden
stool
abdomin
lesion
often
evid
palpat
sometim
associ
local
pain
cat
dri
fip
thorac
involv
chest
lesion
usual
local
one
part
system
infect
small
granuloma
may
involv
pleura
underli
lung
parenchyma
fig
involv
pericardium
describ
lead
fluid
distent
pericardi
sac
cardiac
tamponad
heart
failur
cn
involv
frequent
cat
dri
fip
tabl
onehalf
cat
inflammatori
diseas
cn
fip
well
one
sixth
total
number
cat
show
cn
sign
caus
fip
also
common
diseas
spinal
cord
cat
less
year
age
one
three
lead
caus
along
lymphosarcoma
vertebr
neoplasia
spinal
diseas
among
cat
age
cat
cn
fip
less
year
age
often
origin
larg
multipl
cat
household
cn
involv
cat
dri
fip
vari
clinic
express
depend
organ
involv
tabl
exact
local
nervou
system
sever
sign
refer
spinal
cord
involv
posterior
paresi
incoordin
hyperesthesia
seizur
palsi
brachial
trigemin
facial
sciatic
nerv
report
hydrocephalu
secondari
diseas
choroid
ependyma
also
document
lead
dementia
person
chang
aggress
rage
hidingwithdraw
etc
convuls
disord
cerebellarevestibular
sign
nystagmu
head
tilt
circl
also
caus
fip
ocular
involv
like
cn
diseas
much
like
occur
cat
dri
wet
fip
tabl
uveiti
chorioretin
predomin
ocular
manifest
dri
fip
fig
fip
also
frequent
caus
uveitischorioretin
cat
less
common
caus
felvassoci
lymphosarcoma
trauma
toxoplasmosi
lensinduc
uveiti
ocular
diseas
dri
fip
occur
sole
associ
lesion
cn
periton
caviti
tabl
chang
color
iri
frequent
earli
sign
ocular
fip
fig
kerat
precipit
caudal
aspect
cornea
characterist
fip
due
accumul
fibrin
macrophag
inflammatori
cell
fig
focal
lesion
akin
granuloma
parenchymat
organ
may
appar
iri
distort
shape
pupil
fig
sever
uncommon
interest
manifest
dri
fip
granulomat
involv
peripher
tissu
result
priapism
castrat
cat
chronic
fibrin
necrot
orchiti
may
caus
scrotum
testicl
appear
enlarg
scrotal
enlarg
may
one
primari
present
complaint
miscellan
site
lesion
noneffus
fip
includ
nasal
passag
tongu
distal
small
intestin
syringomyelia
caus
involv
fourth
ventricl
one
cat
cutan
lesion
granulomat
type
report
felin
immunodefici
viru
fiv
infect
cat
fip
lesion
thought
due
coronaviru
induc
vasculti
toxic
epiderm
necrolysi
also
observ
cat
dri
fip
nc
pedersen
uc
davi
unpublish
observ
nonpurit
slightli
rais
intraderm
papul
neck
chest
wall
observ
termin
stage
cat
noneffus
progress
effus
fip
fipv
identifi
skin
lesion
immunohistochemistri
lesion
dri
fip
also
mistaken
cancer
particular
lymphoma
one
felv
neg
cat
fip
subsequ
develop
myeloprolif
diseas
monoclon
gammopathi
observ
four
cat
fip
fifth
cat
fip
observ
convert
polyclonalto
monoclonalgammopathi
hurvitz
quot
fip
mani
interest
interact
infecti
agent
agent
may
affect
immun
fipv
felv
infecton
altern
fipv
may
induc
immunosuppress
encourag
opportunist
type
pathogen
concurr
felv
infect
seen
onethird
onehalf
fip
case
test
infect
felv
seem
specif
interf
effect
ongo
immun
fipv
cat
fail
develop
fip
experiment
infect
develop
fip
within
week
becom
felv
virem
indic
mani
fip
recov
cat
maintain
residu
infect
mimick
situat
field
fip
also
appear
natur
exposur
virus
virtual
elimin
felv
pet
cat
popul
western
countri
relationship
becom
much
less
common
affect
kitten
subclin
clinic
fip
suscept
upper
respiratori
infect
caus
mycoplasma
chlamydophila
herpesviru
indic
resist
normal
also
known
cat
advanc
fiv
infect
suscept
fip
expos
fecv
system
toxoplasmosi
rel
rare
clinic
infect
cat
describ
two
cat
fip
one
report
second
report
occurr
system
toxoplasmosi
two
cat
probabl
associ
reactiv
encyst
organ
left
much
earlier
selflimit
infect
fip
frequent
associ
lymphopenia
nonspecif
find
indic
immunosuppress
also
notic
increas
bacteri
infect
cat
fip
manifest
termin
sepsi
chronic
local
infect
intern
organ
nc
pedersen
p
pesavento
uc
davi
unpublish
observ
one
young
cat
chronic
bacteri
infect
reproduct
tract
manifest
earli
purul
vagin
discharg
termin
suppur
infect
ovari
fallopian
tube
second
cat
secondari
bacteri
pneumonia
stress
pregnanc
parturit
surgic
procedur
spay
neuter
declaw
also
increas
incid
uveiti
right
eye
cat
dri
form
fip
color
iri
chang
anterior
chamber
somewhat
hazi
pigment
lesion
center
cornea
kerat
precipit
note
irregular
shape
right
pupil
compar
normal
left
pupil
kerat
precipit
inner
cornea
cat
dri
fip
note
revers
dshape
pupil
due
infiltr
iri
fip
young
cat
suggest
stress
occur
time
young
cat
fight
fipv
infect
may
tip
balanc
host
fipv
enter
target
macrophagemonocyt
first
bind
cell
surfac
intern
clathrin
caveola
independ
dynamin
depend
endocytosi
dewerchin
cowork
ad
upon
find
suggest
viral
antigenantibodi
complex
fip
intern
previous
describ
pathway
intern
process
independ
phosphatas
tyrosin
kinas
depend
serinethreonin
kinas
intern
viral
antigenantibodi
complex
pass
earli
endosom
accumul
late
endosom
complex
left
late
endosom
within
min
degrad
lysosom
bind
involv
specif
attach
site
spike
protein
correspond
cellsurfac
receptor
cellular
receptor
appear
aminopeptidasen
first
identifi
receptor
tge
coronaviru
swine
aminopeptidasen
cellsurfac
metalloproteas
intestin
lung
kidney
epitheli
cell
howev
interact
may
host
speci
specif
nonpermiss
cell
line
genet
engin
express
porcin
aminopeptidasen
becom
permiss
transmiss
gastroenter
viru
tgev
felin
canin
coronavirus
speci
specif
aminopeptidasen
receptor
also
shown
test
intraspeci
chimer
protein
determin
aminopeptidasen
respons
bind
porcin
felin
canin
aminopeptidasen
respect
host
coronavirus
found
cterminu
hohdatsu
et
al
note
differ
receptor
serotyp
ii
fipv
use
block
effect
specif
mous
monoclon
antibodi
find
suggest
felin
aminopeptidasen
receptor
type
fipv
necessarili
type
ii
fipv
interestingli
although
neither
porcin
human
aminopeptidasen
act
receptor
fipv
chimer
abl
act
receptor
fipv
find
suggest
subtl
differ
certain
region
aminopeptidasen
radic
chang
speci
even
serotyp
tropism
acquisit
macrophag
tropism
appear
essenti
step
evolutiontransform
fecv
fipv
larg
nonpathogen
local
enterocyt
pathogen
highli
virul
system
monocytemacrophag
pathogen
relationship
virul
macrophagemonocyt
tropism
firmli
establish
literatur
attach
intern
fipv
monocyt
endocytosi
compar
two
fipv
strain
intern
much
effici
fipvblack
strain
fipv
macrophag
tropic
tissu
cultureadapt
nonvirul
strain
former
viru
assum
prototyp
fipv
latter
assum
prototyp
fecv
howev
assign
isol
prototyp
may
prematur
serotyp
ii
virus
unlik
field
strain
fecv
fipv
tissu
cultureadapt
nonmacrophag
cell
line
unlik
number
serotyp
fipv
except
virul
everi
common
rout
infect
tabl
doubt
appli
prototyp
fecv
lack
gene
present
nontissu
cultureadapt
strain
fecv
attempt
adapt
addit
field
strain
fecv
tissu
cultur
far
fail
also
note
deleteri
mutat
gene
indic
may
origin
fipv
nc
pedersen
uc
davi
person
observ
howev
behav
enter
biotyp
compar
depend
cathepsin
b
cathepsin
l
activ
low
ph
entri
host
cell
also
caus
inappar
mild
enter
infect
laboratori
kitten
target
appropri
tissu
caus
fip
nevertheless
without
bonifi
tissu
cultureadapt
fecv
strain
grown
appropri
host
cell
comparison
macrophag
versu
enterocyt
tropism
fecv
fipv
vitro
use
two
fcov
biotyp
interpret
caution
studi
fecv
undertaken
natur
dealt
system
spread
intestin
tropism
instanc
fecv
may
detect
blood
cours
natur
infect
much
lower
level
seen
fipv
therefor
affin
enter
biotyp
intestin
epithelium
fig
fip
biotyp
macrophag
may
quantit
qualit
genet
basi
differ
macrophag
tropism
fecv
fipv
fulli
understood
would
logic
assum
differ
due
characterist
function
mutat
gene
howev
research
suggest
acquisit
macrophag
tropism
fipv
determin
mutat
spike
protein
unfortun
studi
also
compar
appear
typic
either
respect
biotyp
mutant
virus
fipv
phenotyp
detect
high
primari
fecv
infect
indic
macrophag
tropic
mutant
occur
great
frequenc
howev
fraction
mutant
may
actual
produc
progress
diseas
abort
infect
thought
associ
strong
rapid
cellular
immun
respons
probabl
contain
within
mesenter
lymph
node
unfortun
cat
mutant
virus
allow
prolifer
uncheck
within
macrophag
carri
cell
specif
site
bodi
mani
tissu
organ
appear
fed
cranial
mesenter
arteri
rich
phagocyt
cell
target
mesenter
lymph
node
seros
surfac
gut
lesser
extent
pleura
omentum
viru
also
appear
reach
mening
especi
posteriorventr
surfac
brain
ependyma
surround
ventricl
dura
mater
spinal
cord
uveal
tract
retina
eye
issu
whether
differ
variant
fipv
exist
cat
rais
battilani
et
al
analyz
quasispeci
composit
phylogenet
relationship
coronavirus
cat
natur
acquir
fip
use
singlestrand
conform
polymorph
nucleocapsid
gene
found
high
degre
heterogen
especi
nucleocapsid
gene
correl
directli
serious
clinic
diseas
sequenc
also
vari
accord
geograph
origin
exist
quasispeci
cat
fip
recent
confirm
author
laboratori
two
four
sibl
cat
die
fip
found
two
distinct
variant
tissu
two
variant
fece
time
nc
pedersen
hw
liu
uc
davi
person
observ
recent
publish
immunohistochem
studi
brain
lesion
cat
dri
form
fip
use
two
differ
monoclon
antibodi
direct
unrel
epitop
ccv
search
variant
author
also
use
myeloidhistiocyt
marker
identifi
infect
macrophag
doubl
immunostain
demonstr
macrophag
posit
either
ccvmonoclon
antibodi
alon
ccvand
fipvmonoclon
antibodi
conclus
two
cohort
phagocyt
contain
viru
ccvepitop
differ
presenc
absenc
fipv
epitop
unfortun
strength
reactiv
two
monoclon
antibodi
differ
author
consid
variou
macrophag
contain
differ
amount
antigen
give
impress
differenti
stain
given
origin
fipv
surpris
similar
phenomenon
observ
cat
infect
natur
experiment
fecv
cat
shed
fecv
fece
throughout
experi
without
diseas
sign
sequenc
nucleocapsid
gene
amplifi
revers
transcriptas
polymeras
chain
reaction
rtpcr
cerebr
cortex
dura
mater
pancrea
lung
third
eyelid
heart
muscl
four
cat
virus
differ
organ
whether
express
gene
nucleocapsid
gene
sequenc
viru
replic
macrophag
appear
slow
first
week
dramat
increas
level
macrophag
infiltr
macrophag
infect
viru
replic
viral
spread
occur
around
day
primari
infect
experiment
infect
coincident
appear
viru
specif
antibodi
recoveri
occur
probabl
take
place
sometim
initi
quiescent
period
antibodi
viru
neutral
vitro
appear
diseas
facilit
effect
vivo
failur
antibodi
respons
neutral
prevent
viru
spread
vivo
explain
least
two
way
first
antibodi
bind
viru
may
block
aminopeptidasen
receptor
prevent
virustocel
attach
enhanc
viru
uptak
macrophag
complement
bind
fc
receptor
antibodymedi
enhanc
specif
felin
antibodi
felin
macrophag
may
involv
antibodi
viru
spike
membran
protein
second
viral
antigen
may
array
surfac
infect
macrophag
thu
limit
viru
spread
intim
celltocel
contact
hallmark
antibodi
phase
infect
rapidli
spread
serosaloment
center
inflamm
associ
expand
cycl
macrophag
infect
viru
replic
viru
releas
die
infect
macrophag
yet
viru
bound
yet
macrophag
reaction
center
small
venul
result
lesion
call
pyogranuloma
pyogranuloma
form
around
small
venul
target
tissu
surround
influx
proteinrich
edema
fluid
sprinkl
lymphocyt
neutrophil
plasma
cell
reaction
liken
arthustyp
hypersen
sitiv
cytokin
inflammatori
mediat
releas
macrophag
polymorphonuclear
leukocyt
undoubtedli
add
charact
intens
lesion
complement
activ
vascular
damag
result
dissemin
intravascular
coagulopathi
dic
usual
clinic
appreci
cat
natur
much
less
like
develop
overt
hemorrhag
dic
dic
may
contribut
mucin
natur
fip
exud
yellowish
bluish
ting
fluid
serum
urin
often
found
cat
fip
also
due
microhemorrhag
red
cell
damag
result
vascul
complement
clot
factor
activ
dic
red
blood
cell
leak
tissu
manag
make
spleen
damag
state
destroy
phagocyt
attempt
made
recycl
hemoglobin
break
biliverdin
bilirubin
carrier
protein
biliverdin
bilirubin
rapidli
satur
cat
allow
build
detect
level
exud
serum
urin
tissu
occurr
two
form
fip
effus
wet
nonparenchymat
noneffus
dri
parenchymat
long
intrigu
observ
experiment
natur
infect
cat
show
dri
fip
often
preced
brief
episod
wet
fip
lesion
dri
fip
therefor
remnant
initi
surfac
orient
infect
dri
fip
may
also
becom
effus
termin
stage
diseas
immun
system
collaps
dri
form
fip
presum
result
state
partial
protect
immun
protect
immun
fipv
larg
cell
mediat
involv
chang
way
infect
macrophag
respond
viru
vice
versa
infect
macrophag
receiv
proper
signal
host
gain
capac
destroy
viru
rather
act
viru
incub
dissemin
host
also
come
view
infect
macrophag
foreign
attempt
destroy
well
cellular
immun
develop
earli
cours
infect
suffici
strength
clinic
sign
diseas
occur
viru
replic
check
viru
may
persist
subclin
latent
state
like
within
macrophag
organ
mesenter
lymph
node
month
even
year
humor
immun
occur
cellular
immun
fail
develop
result
diseas
effus
wet
howev
intermedi
stage
immun
also
occur
strong
humor
immun
weak
cellular
immun
viru
contain
much
greater
extent
effus
form
diseas
fulli
elimin
tug
war
viru
replic
viru
destruct
follow
result
noneffus
dri
form
fip
form
diseas
character
classic
granuloma
unlik
pyogranuloma
fill
viru
laden
macrophag
scatter
neutrophil
lymphocyt
granuloma
contain
small
foci
macrophag
center
mani
contain
small
amount
viral
antigen
surround
broad
band
lymphocyt
plasma
cell
granulomat
lesion
dri
fip
less
common
much
less
widespread
pyogranuloma
wet
fip
tend
extend
surfac
organ
underli
parenchyma
surfac
orient
granuloma
consist
origin
pyogranuloma
organ
distribut
lesion
dri
fip
also
explain
state
partial
weak
immun
initi
stage
fipv
infect
viru
reach
brain
eye
via
infect
monocyt
immun
difficulti
penetr
area
due
bloodbrain
barrier
protect
immun
strong
viru
virusinfect
cell
easili
clear
organ
side
bloodbrain
barrier
howev
protect
immun
weak
effect
handl
viru
virusinfect
cell
core
bodi
eye
brain
therefor
lesion
brain
eye
like
persist
lesion
abdomen
site
thu
provid
explan
ocular
cn
lesion
predomin
dri
form
fip
diagnosi
fip
rel
simpl
given
affin
younger
cat
strong
tendenc
involv
catteri
shelter
typic
physic
histor
find
numer
characterist
laboratori
abnorm
nonetheless
somehow
remain
one
difficult
diagnos
mani
veterinarian
truth
veterinarian
littl
troubl
place
fip
high
top
diagnost
list
great
difficulti
even
reluct
confirm
diagnosi
howev
veterinarian
difficulti
owner
well
reluct
give
without
definit
diagnosi
must
rememb
diagnosi
base
cumul
odd
rather
singl
simpl
definit
test
result
young
cat
catteri
shelter
chronic
uveiti
andor
neurolog
sign
high
serum
protein
hyperglobulinemia
hypoalbuminemia
fluctuat
antibiot
unrespons
fever
leukocytosi
lymphopenia
anemia
chronic
diseas
diseas
dri
fip
base
odd
alon
likewis
cat
similar
histori
laboratori
find
yellowting
mucin
inflammatori
ascit
instead
uveiti
neurolog
sign
highli
unlik
diseas
wet
fip
result
test
incorrectli
tout
definit
highli
indic
fip
confus
issu
induc
doubt
diagnosi
doubt
ultim
fip
must
diagnos
appli
workabl
knowledg
diseas
sensibl
weigh
signal
histori
clinic
sign
clinicopatholog
find
serolog
anteor
postmortem
examin
affect
tissu
histopatholog
immunohistochemistri
hemogram
cat
fip
often
demonstr
sever
abnorm
tend
similar
regardless
form
diseas
lowgrad
moder
nonrespons
anemia
hypoalbuminemia
typic
chronic
diseas
common
hematolog
chang
includ
leukocytosi
absolut
lymphopenia
neutrophilia
hyperproteinaemia
serum
total
protein
elev
associ
increas
level
globulin
decreas
level
albumin
cat
viru
posit
lymph
node
necropsi
purportedli
like
globulin
elev
hypergammaglobulinemia
directli
relat
fcov
antibodi
titer
suggest
nonspecif
antibodi
globulin
andor
complement
factor
import
contributor
globulin
elev
albumin
globulin
ratio
consid
diagnost
inflammatori
process
commonli
fip
consist
chang
shown
serum
protein
electrophoresi
increas
gglobulin
haptoglobin
make
increas
abdomin
pleural
effus
fip
characterist
definit
singl
test
almost
onehalf
effus
cat
due
fip
therefor
odd
fip
presenc
effus
alon
effus
featur
fip
odd
even
greater
cat
younger
odd
greater
still
cat
shelter
catteri
odd
go
even
etc
fip
effus
usual
light
dark
yellow
occasion
greenting
due
elev
level
bilirubin
biliverdin
respect
fluid
mucin
charact
drop
slide
touch
needl
tip
pull
away
string
often
form
fluid
rang
somewhat
clear
cloudi
often
contain
visibl
fibrin
tag
protein
content
effus
rang
mgml
globulin
compris
total
cell
count
rang
per
ml
macrophag
nontox
neutrophil
lymphocyt
predomin
fluid
effus
particularli
pleural
caviti
may
ting
red
cell
effus
often
form
partial
clot
allow
sit
anticoagul
free
tube
electrophoret
pattern
effus
similar
correspond
serum
antibodi
titer
higher
correspond
serum
often
detect
effus
like
compar
antibodi
titer
serum
cerebrospin
fluid
csf
signific
find
determin
definit
diagnosi
made
direct
immunohistochem
examin
cell
fluid
viral
antigen
immunofluoresc
sever
time
sensit
immunoperoxidas
realtim
rtpcr
analysi
cell
fip
effus
demonstr
high
level
viral
rna
hyperbilirubinemia
less
commonli
hyperbiliverdinemia
frequent
without
jaundic
common
cat
fip
especi
effus
form
fact
fip
common
caus
icter
serum
plasma
cat
year
age
urin
also
yellowting
due
hyperbilirubinuria
greenish
hue
urin
serum
less
common
due
high
level
biliverdin
increas
level
bilirubin
biliverdin
blood
usual
due
liver
involv
per
se
rather
microhemorrhag
tissu
extravascular
destruct
red
blood
cell
phagocyt
cell
part
vascul
dic
heme
destroy
red
cell
recycl
biliverdin
final
bilirubin
cat
defici
carrier
system
remov
hemoglobin
breakdown
product
blood
henc
tendenc
accumul
effus
lesion
serum
aqueou
humor
csf
cat
ocular
cn
diseas
also
show
similar
variabl
increas
protein
leukocyt
typic
csf
find
cat
fip
includ
protein
concentr
greater
mgdl
white
cell
count
cellsml
consist
predominantli
neutrophil
contrast
csf
cat
viral
diseas
usual
protein
concentr
less
mgdl
total
white
cell
count
less
cellsml
singh
et
al
defin
inflammatori
csf
total
nucleat
cell
count
greater
cellsml
one
total
count
normal
differenti
count
abnorm
gender
degre
csf
inflamm
neuroanatom
locat
system
sign
provid
help
determin
whether
inflamm
due
fip
diseas
cryptococcu
lymphoma
trauma
synovi
fluid
cat
effus
fip
frequent
inflammatori
charact
mani
serum
antibodi
test
use
diagnosi
fip
includ
indirect
immunoflouresc
antibodi
ifa
viru
neutral
enzymelink
immunosorb
assay
elisa
feel
elisa
sensit
procedur
author
feel
antibodi
test
equival
done
properli
common
test
ifa
assay
use
tge
viru
fipv
infect
swine
cat
cell
substrat
titer
usual
read
distinct
multipl
serum
dilut
origin
report
help
diagnos
cat
fip
suffer
ill
unfortun
coronaviru
antibodi
differenti
cat
infect
fecv
fipv
although
high
titer
highli
suggest
fip
neg
titer
tend
rule
fip
overlap
titer
healthi
coronavirusexpos
diseas
cat
great
littl
definit
diagnost
valu
individu
anim
titer
appear
rise
progress
mani
cat
go
subclin
clinic
stage
diseas
howev
progress
monitor
titer
rare
done
titer
usual
measur
diseas
sign
appear
titer
level
alreadi
plateau
moreov
titer
may
also
fall
dramat
end
especi
cat
fulmin
effus
fip
sensit
specif
socal
fip
serolog
repeatedli
question
hematolog
antibodi
titer
serum
protein
electrophoresi
cat
effus
noneffus
form
affect
fip
studi
compar
healthi
cat
effus
form
antibodi
titer
protein
electrophoresi
effus
analyz
seroposit
anim
antibodi
titer
present
among
fip
infect
healthi
cat
spark
et
al
also
compar
serolog
data
cat
fip
consid
differenti
diagnosi
end
anoth
diseas
found
presenc
multipl
abnorm
compat
fip
increas
specif
ie
decreas
fals
posit
decreas
sensit
diagnosi
ie
increas
fals
neg
howev
doubt
cat
low
neg
fcov
antibodi
titer
less
like
fip
cat
high
titer
like
given
limit
author
recommend
fip
serolog
test
use
aid
rule
possibl
fip
diagnosi
fip
never
made
antibodi
titer
alon
recommend
made
other
mani
attempt
improv
specif
sensit
antibodi
base
test
fip
one
commerci
test
measur
antibodi
titer
protein
fcov
base
presumpt
prototyp
fecv
lack
protein
prototyp
fipv
intact
protein
theori
cat
fip
antibodi
protein
cat
expos
common
fecv
would
antibodi
unfortun
lack
protein
artifact
specif
isol
field
strain
fecv
intact
gene
therefor
antibodi
test
specif
sensit
indirect
ifa
test
substanti
publish
studi
vagari
fip
serolog
fip
antibodi
test
also
use
mean
control
elimin
fip
catteri
vast
amount
money
spent
year
catteri
owner
fip
test
almost
case
result
noninterpret
even
veterinarian
order
test
virtual
catteri
six
eight
cat
activ
breed
program
fecv
catteri
anim
titer
greater
usual
catteri
test
usual
confirm
alreadi
known
fecv
enzoot
catteri
antibodi
titer
answer
critic
question
cat
actual
fip
cat
subclin
infect
fipv
particular
cat
develop
fip
futur
cat
shed
fecv
overand
misinterpret
variou
coronaviru
antibodi
test
result
consider
mortal
senseless
euthanasia
healthi
cat
undu
emot
financi
stress
serolog
also
appli
diagnosi
neurolog
form
fip
foley
et
al
observ
believ
specif
fcov
antibodi
product
within
cn
found
use
antemortem
indic
neurolog
fip
posit
igg
anticoronaviru
antibodi
titer
csf
high
serum
total
protein
concentr
magnet
reson
imag
mri
find
suggest
periventricular
contrast
enhanc
ventricular
dilat
hydrocephalu
diagnost
valu
posit
anticoronaviru
antibodi
titer
csf
later
question
boettcher
et
al
collect
csf
four
clinic
group
cat
fip
involv
cn
n
cat
fip
involv
cn
n
cat
cn
disord
caus
diseas
fip
n
cat
diseas
fip
involv
cn
n
csf
evalu
concentr
erythrocyt
leukocyt
total
protein
anticoronaviru
igg
measur
csf
serum
indirect
ifa
csf
igg
detect
cat
includ
six
cat
neurolog
manifest
fip
four
cat
fip
involv
cn
two
cat
brain
tumor
csf
igg
detect
cat
correspondingli
high
serum
igg
titer
significantli
correl
serum
igg
titer
anoth
attempt
measur
local
cn
antibodi
product
cat
fip
steinberg
et
al
use
albumin
quotient
igg
index
determin
whether
protein
csf
blood
local
origin
neither
albumin
quotient
igg
index
identifi
pattern
consist
intrathec
igg
synthesi
cat
cn
form
fip
conclus
variou
studi
coronaviru
antibodi
enter
csf
high
level
serum
high
serum
titer
like
associ
dri
form
fip
neurolog
case
fip
dri
type
tabl
therefor
posit
fcov
antibodi
titer
csf
like
associ
fip
test
presenc
fipv
rna
develop
suffer
mani
weak
serolog
popular
pcr
base
test
base
lack
gene
fecv
prototyp
presenc
fipv
prototyp
mention
lack
gene
one
isol
artifact
probabl
tissu
cultur
adapt
therefor
pcr
test
base
genet
differ
invalid
moreov
pcr
test
notori
suscept
laboratori
contamin
dna
product
amplif
mani
commerci
laboratori
procedur
uncontrol
manner
attempt
increas
specif
sensit
pcr
develop
would
detect
form
viral
rna
present
replic
stage
rational
replic
form
viral
rna
would
found
blood
cat
fip
test
design
amplifi
subgenom
mrna
highli
conserv
gene
test
appli
healthi
cat
suspect
fip
almost
onehalf
diseas
cat
posit
replic
form
fcov
mrna
peripher
blood
cell
wherea
healthi
cat
test
posit
seventyf
cat
postmortem
confirm
fip
test
posit
wherea
nonfip
case
test
neg
optimist
result
found
test
appli
anoth
group
cat
studi
blood
sampl
collect
healthi
cat
one
cat
clinic
sign
suggest
fip
name
fever
weight
loss
enlarg
abdomen
ascit
blood
sampl
test
replic
fcov
messeng
rna
procedur
simon
et
al
fourteen
cat
posit
fcov
includ
cat
clinic
diseas
high
rate
posit
also
observ
among
healthi
cat
suggest
felin
coronavirus
may
present
blood
sampl
healthi
cat
well
cat
clinic
fip
suggest
confirm
healthi
cat
other
conflict
find
call
question
valu
pcr
test
blood
howev
rtpcr
accur
differenti
fip
effus
effus
caus
problem
laboratori
contamin
pcr
product
virtual
elimin
use
techniqu
call
realtim
pcr
taqman
clinician
catteri
owner
test
fcov
fece
pcr
attempt
identifi
fecv
carrier
within
group
cat
elimin
shedder
environ
mean
prevent
fip
loss
fecv
shed
high
level
fece
carrier
rate
higher
mani
multicat
popul
shed
intermitt
infect
recurr
review
pedersen
et
al
pcr
inhibitor
describ
fece
import
purifi
viral
rna
use
certain
method
test
expens
laboratori
reliabl
commerci
basi
howev
final
analysi
virtual
imposs
maintain
group
cat
free
viru
even
infect
elimin
without
strict
quarantin
facil
measur
well
restrict
movement
cat
peopl
cat
popul
see
treatment
prevent
rivalta
test
tout
diagnosi
wet
fip
test
tube
fill
distil
water
one
drop
acet
acid
ad
follow
drop
periton
pleural
effus
drop
dissip
solut
test
neg
drop
retain
shape
test
posit
neg
rivalta
test
reportedli
accur
rule
fip
posit
test
accur
rule
fip
author
see
improv
diagnost
valu
test
routin
gross
microscop
biochem
analysi
fluid
simpl
cheap
support
test
sever
indirect
test
usual
base
level
certain
inflammatori
protein
byproduct
acut
phase
reactant
use
detect
inflammatori
condit
cat
particular
fip
review
paltrinieri
et
al
glycoprotein
agp
acut
phase
protein
increas
concentr
infecti
inflammatori
condit
serum
periton
fluid
concentr
agp
found
use
diagnosi
fip
amyloid
agp
increas
hour
inflammatori
stimulu
remain
elev
long
inflamm
persist
evalu
cat
serum
agp
level
also
use
studi
fip
group
cat
serum
agp
concentr
observ
fluctuat
time
clinic
healthi
cat
catteri
highest
preval
fip
significantli
increas
outbreak
fip
although
increas
level
agp
inflammatori
protein
particularli
common
cat
fip
specif
level
agp
usual
high
cat
fip
inflammatori
diseas
moder
serum
agp
level
mgml
discrimin
cat
fip
diseas
low
pretest
probabl
high
serum
agp
level
mgml
usual
seen
cat
diseas
fip
howev
specif
increas
agp
level
question
other
potenti
valu
rais
level
acut
phase
reactant
agp
haptoglobin
diagnosi
fip
examin
cat
confirm
fip
cat
condit
level
agp
greater
gl
serum
plasma
effus
sampl
found
valu
distinguish
field
case
fip
cat
similar
clinic
sign
differenti
two
group
cat
effect
albumin
globulin
ratio
concentr
haptoglobin
higher
cat
fip
group
healthi
cat
suffici
diagnost
valu
serum
sampl
fivinfect
cat
also
significantli
elev
level
agp
haptoglobin
illustr
rais
level
inflammatori
protein
pathognomon
fip
modif
agp
also
test
increas
specif
agp
human
heavili
glycosyl
undergo
sever
modif
glycan
moieti
acut
chronic
inflammatori
process
use
human
test
modif
felin
agp
littl
lfucos
residu
surfac
branch
degre
low
normal
sever
patholog
condit
contrast
felin
agp
underw
sever
modif
acut
fip
includ
decreas
express
link
link
sialic
acid
respect
compar
nonpatholog
felin
agp
possibl
role
acut
phase
inflammatori
protein
immunoglobulin
pathogenesi
diagnosi
fip
also
report
giordano
et
al
serum
protein
electrophoresi
concentr
haptoglobin
hp
serum
amyloid
saa
agp
igg
igm
evalu
healthi
coronavirusexpos
cat
cat
fip
highest
concentr
acut
phase
protein
detect
affect
cat
confirm
role
protein
support
clinic
diagnosi
fip
interestingli
healthi
coronavirusexpos
cat
also
increas
acut
phase
protein
time
member
group
develop
fip
appear
group
howev
increas
persist
cat
develop
fip
appar
variou
studi
level
agp
well
inflammatori
protein
chang
dramat
fip
none
chang
definit
right
mri
proven
use
confirm
presenc
inflammatori
neurolog
diseas
indic
csf
analysi
fourteen
cat
inflammatori
diseas
affect
cn
review
includ
eight
cat
fip
two
cat
toxoplasmosi
abnorm
affect
cn
observ
mr
imag
cat
intracrani
lesion
appear
slightli
hypointens
foci
imag
two
cat
hyperintens
foci
imag
seven
cat
hyperintens
foci
intraven
administr
gadoliniumbas
contrast
medium
cat
six
cat
lesion
imag
addit
lesion
visibl
imag
obtain
gadoliniumbas
contrast
medium
administr
three
cat
lesion
visibl
contrast
medium
administr
mri
studi
detect
case
cn
inflamm
popul
cat
inflammatori
csf
howev
add
inform
locat
lesion
import
differenti
fip
inflammatori
condit
substanti
conclus
earlier
mri
studi
cat
neurolog
fip
sixteen
domest
cat
confirm
neurolog
fip
eight
control
cat
nonneurolog
fip
studi
preand
antemortem
mri
imag
demonstr
periventricular
contrast
enhanc
ventricular
dilat
hydrocephalu
cat
neurolog
fip
present
gold
standard
fip
diagnosi
immunohistochemistri
effus
lesion
contain
infect
macrophag
monoclon
polyclon
antibodi
highli
fcov
specif
react
well
formalin
fix
tissu
use
section
lesion
cell
pellet
ascet
pleural
fluid
directli
examin
viru
use
fluorescein
horseradish
peroxidas
polyclon
monoclon
antibodi
detect
coronaviru
antigen
fip
effus
specif
less
sensit
detect
viral
antigen
characterist
fip
parenchym
lesion
hirschberg
et
al
identifi
antigen
confirm
fip
effus
wherea
effus
due
caus
neg
specif
immunohistochemistri
factor
polyor
monoclon
antibodi
use
characterist
local
fipv
antigen
within
macrophag
sensit
test
depend
infect
macrophag
tissu
exud
cell
slide
reason
random
biopsi
liver
kidney
cat
fip
often
fail
yield
fipv
antigen
immunohistochemistri
would
true
realtim
pcr
sensit
five
time
greater
fluorescein
horseradish
peroxidas
stain
latter
advantag
use
formalin
fix
paraffin
embed
tissu
former
requir
frozen
section
tissu
use
equal
eas
slide
cell
harvest
effus
aceton
fix
viru
isol
tissu
cultur
yet
possibl
fecv
difficult
field
strain
fipv
serotyp
ii
fipv
seem
grow
better
tissu
cultur
often
grow
crandel
felin
kidney
crfk
cell
latter
cell
line
macrophag
lineag
prefer
cell
line
isol
serotyp
fipv
cost
low
yield
cell
cultur
isol
prohibit
routin
applic
clinic
diagnosi
follow
introduct
test
detect
felv
infect
onethird
cat
fip
found
concomit
felv
infect
elimin
felv
mani
catteri
pet
cat
household
steadi
declin
incid
felv
entir
cat
popul
proport
cat
fip
concurr
felv
infect
greatli
decreas
present
virtual
case
fip
purebr
catterybr
cat
felv
neg
felv
infect
detect
less
domest
pet
cat
fip
principl
lesion
effus
fip
pyogranuloma
infect
character
distinct
form
vascul
ie
phlebiti
pyogranuloma
wet
fip
particularli
preval
abdomen
liter
cover
seros
surfac
abdomin
organ
fig
rang
microscop
sever
millimet
size
sometim
becom
confluent
fibrin
sheet
fig
pyogranuloma
effus
fip
tend
follow
cours
cranial
mesenter
arteri
therefor
concentr
omentum
seros
surfac
abdomin
viscera
tabl
omentum
often
thicken
edema
inflammatori
infiltr
necrosi
retract
compact
mass
fig
lesion
less
common
thorax
center
pleura
pericardium
tabl
pyogranuloma
made
central
aggreg
macrophag
adjac
small
venul
surround
rich
inflammatori
exud
contain
mainli
neutrophil
macrophag
scatter
plasma
cell
tlymphocyt
fig
almost
macrophag
within
pyogranuloma
cat
wet
fip
contain
viral
antigen
high
concentr
fig
consider
amount
fibrin
proteinrich
fluid
also
deposit
within
around
lesion
necrosi
often
evid
though
pyogranulomat
process
usual
surfac
orient
focal
lesion
phlebiti
mix
inflammatorycel
infiltr
may
seen
deep
underli
muscl
organ
parenchyma
lesion
dri
fip
also
refer
pyogranuloma
close
resembl
classic
granuloma
outward
appear
especi
abdomen
fig
lesion
dri
fip
typic
contain
foci
macrophag
around
vessel
reminisc
lesion
effus
fip
howev
foci
surround
dens
infiltr
lymphocyt
mainli
bcell
plasma
cell
extend
surround
tissu
seen
classic
granuloma
fig
edema
hyperemia
necrosi
fibrin
deposit
protein
exud
pronounc
pyogranulomat
lesion
effus
fip
abdominalpleur
lesion
dri
fip
describ
extraperiton
probabl
origin
serosa
pleura
invad
along
vessel
underli
parenchyma
granuloma
especi
abdomen
vari
size
microscop
sever
centimet
diamet
larger
lesion
mistaken
outwardli
cancer
lymphoma
similar
pyogranuloma
wet
fip
granuloma
dri
fip
also
apt
occur
abdomen
kidney
mesenter
lymph
node
liver
caecumcolon
uncommon
chest
caviti
tabl
fig
lesion
eye
cn
much
frequent
seen
cat
dri
wet
fip
may
occur
absenc
presenc
abdominalthorac
lesion
lesion
within
brain
spinal
cord
eye
tend
smaller
found
abdomen
similar
natur
lesion
effus
fip
cn
lesion
center
mening
ependyma
also
extend
underli
brain
spinal
cord
spinal
nerv
lesion
particularli
common
posteriorventr
aspect
brain
ocular
lesion
fip
well
studi
common
morpholog
featur
lymphocyt
plasmacyt
anterior
uveal
infiltr
either
diffus
nodular
manifest
grossli
swell
discolor
iri
foci
granulomat
involv
sometim
observ
kerat
muttonfat
precipit
common
back
side
cornea
fig
precipit
made
mainli
macrophag
inflammatori
cell
fibrin
exud
inflam
uveal
tract
lymphoid
lesion
common
effus
noneffus
fip
splenic
enlarg
may
due
histiocyt
plasmacyt
infltrat
red
pulp
hyperplasia
lymphoid
element
white
pulp
necrot
spleniti
fibrin
deposit
polymorphonuclear
cell
infltrat
common
wet
fip
organ
pyogranulomat
reaction
common
dri
fip
gross
lymph
node
enlarg
usual
limit
thorac
abdomin
node
lesion
resembl
describ
spleen
kipar
et
al
report
lymphoid
organ
lesion
cat
fip
cat
resist
experiment
infect
cat
fip
precardi
mediastinum
includ
site
thymu
mesenter
lymph
node
parenchyma
often
affect
granulomatousnecrot
process
gener
lymphoid
tissu
show
tand
bcell
deplet
often
includ
massiv
complet
thymic
involut
atrophi
case
number
apoptot
lymphocyt
increas
lymphoid
follicl
well
tcell
zone
number
macrophag
increas
splenic
red
pulp
contrast
fipvexpos
cat
without
fip
gener
show
lymphoid
hyperplasia
fluoresc
immunoperoxidas
antibodi
stain
tissu
section
cat
form
diseas
show
fipv
lesion
effus
fip
larg
amount
viral
antigen
contain
phagocyt
cell
make
larg
part
pyogranuloma
fig
less
viral
antigen
present
lesion
noneffus
fip
fig
lesion
effus
fip
fig
lesion
associ
necrosi
mainli
pyogranuloma
therefor
contain
viru
lesion
without
necrosi
mainli
granuloma
plasma
cell
within
lesion
found
produc
coronaviru
specif
antibodi
lesion
especi
pyogranuloma
effus
fip
also
demonstr
larg
amount
bound
experiment
infect
studi
initi
concentr
highli
virul
strain
fipv
ident
studi
strain
give
impress
virtual
cat
infect
fipv
develop
diseas
die
tabl
howev
atyp
virul
eas
growth
nonmacrophag
type
cell
crfk
fibroblast
cell
ccvlike
spike
protein
virul
serotyp
isol
still
less
virul
interestingli
outbreak
fip
extrem
high
morbid
mortal
uncommon
natur
suggest
highli
virul
laboratori
strain
atyp
born
experiment
infect
studi
yet
isol
fipv
tabl
first
experiment
evid
relationship
fecv
fipv
came
studi
enzoot
fecv
infect
coloni
convent
cat
use
felv
research
presenc
fcov
among
coloni
cat
becom
evid
cat
horizont
expos
felv
natur
contact
began
die
fip
presenc
two
virtual
indistinguish
coronavirus
among
cat
one
infect
gut
caus
littl
diseas
anoth
capabl
caus
fip
later
report
pedersen
et
al
studi
result
isol
fecvucd
relationship
given
credenc
inadvert
introduct
fecv
name
fecvrogersmorri
fecvrm
barrier
contain
research
coloni
specif
pathogenfre
spf
cat
case
fip
sever
year
among
hundr
kitten
first
indic
coloni
infect
fecv
fipv
mutat
confirm
infect
cat
longterm
fiv
infect
cohort
nonfivinfect
sibl
fecvrm
hypothes
fiv
immunocompromis
host
would
replic
fecv
higher
level
lead
greater
chanc
mutat
mutant
viru
would
like
manifest
immun
suppress
host
fecvrm
replic
higher
level
fivinfect
cat
die
fip
within
week
death
fip
seen
cohort
nonfivinfect
sibl
studi
establish
fipv
mutat
fig
much
smaller
porport
macrophag
stain
felin
coronaviru
antigen
pyrogranuloma
effus
fip
fig
conclus
studi
age
suscept
undertaken
studi
use
kitten
younger
cat
direct
evid
kitten
suscept
infect
howev
indirect
evid
cat
vaccin
week
age
attenu
live
fip
vaccin
appar
suscept
challengeexposur
less
respons
vaccin
nc
pedersen
uc
davi
person
observ
deduc
christianson
et
al
gerber
et
al
sixteen
week
also
time
immun
system
cat
reach
nearadult
level
matur
infect
tissu
cultureadapt
strain
fipv
often
mixtur
virus
predomin
viru
may
virul
variant
may
aris
cultur
may
present
cat
prior
cultur
nc
pedersen
unpublish
observ
three
fipv
strain
japan
kukh
examin
biolog
properti
virul
larg
small
plaqu
form
virus
identifi
cultur
isol
nonplaqu
purifi
viru
strain
induc
fip
cat
respect
interestingli
kitten
inocul
larg
plaqu
one
isol
kukh
develop
fip
cat
inocul
small
plaqu
form
succumb
fip
strain
fipv
exist
low
high
passag
form
low
passag
form
virul
high
passag
form
nonvirul
revers
nonvirul
occur
cultur
virul
form
vivo
may
also
predomin
form
vitro
instanc
difficult
reisol
form
grow
tissu
cultur
even
though
cat
inocul
tissu
cultureadapt
viru
nc
pedersen
uc
davi
person
observ
also
studi
cat
natur
acquir
fip
two
genet
variant
tissu
time
nc
pedersen
uc
davi
person
observ
incub
period
clinic
outcom
fipv
infect
depend
strain
viru
immunolog
respons
host
experiment
studi
use
serotyp
strain
fipv
low
moder
virul
best
reflect
happen
natur
tissu
cultur
strain
type
includ
fipvblack
low
passag
moder
virul
strain
even
less
virul
tabl
even
though
low
virul
laboratori
strain
fipvexist
experiment
studi
high
virul
serotyp
strain
serotyp
ii
strain
almost
cat
inocul
high
virul
isol
regardless
rout
develop
initi
fever
spike
h
follow
second
prolong
fever
start
day
longer
inocul
time
antibodi
appear
subsequ
diseas
cours
almost
alway
effus
type
anim
termin
stage
within
week
site
earli
replic
fipv
studi
follow
oral
inocul
spf
cat
wellcom
strain
fipv
grown
cell
cultur
moder
virul
serotyp
viru
viral
antigen
first
detect
immunofluoresc
tonsil
small
intestin
within
h
inocul
later
found
caecum
colon
mesenter
lymph
node
liver
viru
recov
oropharynx
fece
earli
second
day
inocul
shed
continu
euthanasia
howev
histolog
chang
gut
appear
rel
late
cours
infect
histolog
chang
appear
correl
appear
outward
sign
diseas
often
week
later
appear
viru
fece
oropharynx
appear
sustain
fever
usual
coincid
appear
detect
level
fipv
antibodi
indirect
immunofluoresc
antibodi
techniqu
phenomenon
immun
enhanc
cat
previous
infect
fecv
nondiseas
caus
fipv
cat
passiv
given
fcov
antibodi
healthi
fipdiseas
cat
develop
fever
within
h
rapidli
die
fipv
antigen
antibodi
prime
cat
present
macrophag
larg
mononuclear
cell
tracheobronchi
lymph
node
lung
trachea
postchallengeexposur
day
pcd
liver
spleen
pcd
kidney
omentum
pcd
subsequ
nasal
turbin
thorac
abdomin
lymph
node
thymu
bone
marrow
parotid
salivari
gland
eye
brain
initi
antivir
immunofluoresc
pcd
coincid
onset
viremia
vascular
lesion
system
lesion
character
perivascular
necrot
pyogranulomat
inflamm
phlebiti
thrombosi
fibrin
seros
gener
lymphoid
necrosi
develop
pcd
coronaviruslik
particl
observ
electron
microscopi
cytoplasm
vacuol
smooth
endoplasm
reticulum
degener
macrophag
inflammatori
lesion
time
viremia
delay
kitten
seroneg
time
fipv
infect
antivir
immunofluoresc
tracheobronchi
lymph
node
first
detect
pcd
viremia
occur
pcd
system
necrot
lesion
compar
observ
seroposit
kitten
pcd
occur
seroneg
kitten
pcd
group
kitten
initi
viral
infect
region
lymphoreticular
tissu
follow
viremia
infect
macrophag
reticuloendotheli
organ
liver
spleen
lymph
node
perivascular
locat
experiment
studi
fipv
infect
recent
advanc
develop
molecular
clone
viru
studi
virus
infecti
clone
allow
gene
alter
switch
delet
studi
effect
infect
virul
diseas
propeti
molecular
clone
construct
mainli
process
call
revers
genet
least
three
clone
virus
present
exist
clone
fipv
one
deriv
highli
virul
strain
retain
virul
inocul
experiment
cat
must
state
onset
treatment
proven
effect
cure
cat
fip
spite
claim
cat
develop
fip
inevit
die
diseas
day
week
month
reason
numer
fals
claim
uncertain
spontan
remiss
may
account
least
report
misdiagnosi
remaind
cat
ocular
sign
system
manifest
fip
occasion
gone
remiss
symptomat
treatment
cat
chronic
fever
enlarg
mesenter
lymph
node
histolog
compat
fip
high
coronaviru
titer
gone
remiss
without
treatment
cat
without
overt
sign
fip
demonstr
fibrou
lesion
spleen
liver
necropsi
reason
indic
previou
bout
fip
small
quiescent
lesion
spleen
mesenter
lymph
node
also
found
otherwis
healthi
cat
upon
routin
ovariohysterectomi
therefor
spontan
remiss
occur
least
natur
respons
may
fortuit
coincid
variou
treatment
cure
first
report
tylosin
prednisolon
spark
decad
tylosin
use
treatment
fip
howev
tylosin
effect
fip
interestingli
signific
proport
cat
fip
still
treat
antibiot
one
type
cat
gone
remiss
use
prednisolon
phenylalanin
mustard
cyclophosphamid
anoth
cat
success
treat
prednisolon
phenylalanin
mustard
immunosuppress
drug
regimen
withstood
test
time
number
equal
dubiou
nonspecif
treatment
use
fip
almost
insuffici
patient
number
inadequ
document
infect
lack
essenti
placebo
control
doubl
blind
fipv
sensit
human
b
interferon
vitro
felin
interferon
omega
also
inhibit
fipv
vitro
commerci
avail
mani
countri
felin
interferon
omega
reportedli
induc
complet
partial
remiss
two
third
cat
fip
howev
larger
doubl
blind
studi
treatment
found
total
ineffect
variou
immunosuppress
glucocorticoid
cyclophosphamid
use
drug
may
prolong
life
alter
fatal
outcom
immunostimul
megados
vitamin
numer
nutriceut
also
advoc
found
without
merit
pentoxyfilin
tumor
necrosi
factor
alpha
tnfa
inhibitor
use
cat
fip
base
benefit
treat
type
human
felin
vascul
tnfa
upregul
fip
fip
basic
vacul
howev
treatment
proven
benefici
fallen
use
treat
one
fip
cat
felin
ifng
tnfa
inhibitor
pentoxyfilin
benefici
affect
effect
vaccin
elus
effect
treatment
pedersen
hypothes
ideal
fipv
vaccin
contain
live
viru
would
persist
bodi
subclin
state
induc
state
premonit
immun
howev
success
vaccin
fip
develop
even
though
base
hypothesi
cat
surviv
infect
progress
increas
dose
viru
start
subleth
level
appear
develop
type
immun
howev
approach
clinic
applic
mani
cat
die
becom
immun
immun
appear
tenuou
cat
appear
resist
diseas
develop
fip
month
year
later
indic
persist
subclin
infect
find
support
subsequ
studi
baldwin
scott
first
immun
cat
intratrach
subleth
dose
virul
fipv
follow
high
dose
temperatur
attenu
viru
cat
demonstr
immun
aerosol
challeng
highli
virul
fipv
residu
lesion
found
upon
necropsi
examin
suggest
immun
either
partial
premoniton
type
earli
attempt
use
attenu
live
fipv
strain
fipvblack
high
passag
induc
immun
fail
provid
protect
even
caus
immun
enhanc
similar
find
report
later
virul
attenu
strain
phenomenon
fipv
vaccin
induc
enhanc
recent
review
common
theme
mani
vaccin
approach
temperatur
sensit
mutant
administ
intranas
later
develop
corpor
studi
show
high
degre
efficaci
challeng
highli
virul
immun
ascrib
local
iga
respons
system
cellular
respons
measur
fipvinduc
lymphocyt
prolifer
vaccin
given
two
intranas
dose
week
apart
start
week
older
presum
efficaci
could
shown
cat
vaccin
andor
challengeexpos
younger
age
commerci
vaccin
studi
field
larg
singl
build
shelter
hous
thousand
cat
five
hundr
fivfelv
neg
fcov
antibodi
neg
cat
divid
two
group
prior
put
environ
onehalf
got
intranas
live
vaccin
onehalf
sham
vaccin
cat
follow
month
overal
death
group
howev
two
cat
vaccin
group
develop
fip
month
eight
nonvaccin
cat
succumb
diseas
protect
studi
convinc
valid
use
vaccin
coronaviru
neg
cat
measur
protect
limit
period
time
question
hoskin
et
al
vaccin
spf
cat
intranas
week
age
ad
nonvaccin
control
cat
challengeexpos
oral
week
age
ie
one
vaccin
five
nonvaccin
cat
develop
effus
fip
euthanas
howev
six
remain
vaccin
remain
control
histolog
evid
fip
necropsi
week
later
wolf
critic
studi
use
homolog
challeng
strain
follow
cat
week
second
field
studi
vaccin
fail
prevent
fip
catteri
kitten
immun
presenc
preexist
fecv
antibodi
issu
serotyp
specif
ie
vaccin
serotyp
ii
field
isol
serotyp
interfer
matern
antibodi
need
withhold
vaccin
least
week
rel
poor
efficaci
seriou
limit
vaccin
still
market
use
veterinari
practition
proven
safe
long
period
use
appear
enhanc
diseas
howev
degre
effect
gener
cat
popul
incid
fip
low
catteri
multicat
household
virtual
week
old
alreadi
seroposit
therefor
nonrespons
highli
question
serotyp
crossreact
also
issu
cross
protect
close
relat
virus
tge
viru
ccv
fipv
either
occur
weak
cross
protect
variou
isol
serotyp
may
also
vari
cat
infect
neither
becam
ill
develop
protect
immun
challengeexposur
virul
strain
recov
cat
tend
immun
challeng
recov
cat
good
protect
immun
serotyp
fipv
number
differ
potenti
vaccin
base
recombin
technolog
describ
literatur
sinc
genet
engin
vaccinia
viru
express
envelop
protein
fipv
test
enhanc
virul
fipv
infect
rather
protect
cat
wasmoen
et
al
develop
recombin
raccoon
poxviru
express
gene
encod
nucleocapsid
protein
fipv
use
vaccin
cat
parenter
oral
vaccin
twice
week
apart
infect
oral
fecv
sensit
virul
fipv
three
week
later
cat
oral
challeng
fipv
nonvaccin
control
succumb
fip
cat
vaccin
subcutan
raccoon
recombin
poxviru
develop
fip
one
five
cat
latter
group
die
follow
second
fipv
challeng
suggest
immun
premonit
type
vaccin
induc
serum
antibodi
respons
fipv
nucleocapsid
protein
neutral
suggest
protect
immun
respons
involv
mechan
neutral
antibodi
spike
glycoprotein
fecv
boost
import
immun
subsequ
fate
vaccin
approach
unknown
anoth
studi
spike
gene
clone
vaccinia
viru
use
express
vector
vaccin
vaccin
cat
develop
neutral
antibodi
kitten
vaccin
recombin
vaccinia
viru
die
earlier
anim
vaccin
nativ
vaccinia
viru
alon
plasmid
vaccin
contain
membran
nucleocapsid
n
gene
fail
protect
kitten
challeng
infect
fipv
vaccinia
viru
express
protein
fipv
fail
protect
cat
vaccin
made
cell
lysat
recombin
baculovirusexpress
nucleocapsid
protein
protect
vaccin
versu
cat
immun
control
antigen
haijema
et
al
report
success
vaccin
cat
homolog
viru
challeng
cat
live
fipv
attenu
delet
lesser
extent
gene
cluster
followup
research
report
latter
two
vaccin
approach
antivir
drug
therapi
becom
increasingli
import
number
viral
diseas
human
immunodefici
viru
human
influenza
viru
ribavarin
strongli
inhibitori
fipv
vitro
effect
vivo
dichotomi
vitro
vivo
inhibit
mirror
recent
experi
human
sever
acut
respiratori
syndrom
sar
cornaviru
sixteen
differ
compound
subsequ
test
abil
inhibit
fcov
replic
vitro
six
compound
found
reduc
viru
titer
p
use
cytopath
effect
endpoint
effect
dose
ed
level
six
compound
pyrazofuin
hygromycin
b
fusid
acid
dipyridamol
respect
compound
statist
signific
effect
fipvin
assay
caffeic
acid
carbodin
acid
glucosamin
indomethacin
dpenicillamin
rhodamin
taurin
subsequ
vivo
studi
report
compound
inhibitori
vitro
recent
appear
sar
human
greatli
increas
interest
knowledg
potenti
anticoronavir
drug
wide
varieti
pyridin
noxid
deriv
found
inhibitori
fcov
fipv
strain
human
sarscov
frankfurt
crfk
simian
kidney
vero
cell
cultur
respect
select
compound
activ
high
microgram
per
liter
rang
nontox
mgl
one
activ
select
compound
test
shown
inhibit
fcov
replic
transcript
level
balzarini
et
al
also
demonstr
inhibit
fip
human
sar
coronavirus
semisynthet
deriv
glycopeptid
antibiot
includ
vancomycin
eremomycin
teicoplanin
ristocetin
effect
concentr
ec
activ
deriv
lower
micromolar
rang
ec
valu
differ
fipv
sarscov
indic
consider
differ
speci
specif
vivo
studi
fcov
inhibitori
compound
report
date
indomethacin
recent
found
potent
inhibitori
effect
replic
sar
coronaviru
ccv
studi
done
felin
coronavirus
group
howev
earlier
studi
found
indomethacin
ineffect
fipv
incid
fip
within
catteri
decreas
proper
manag
mortal
tend
increas
popul
anim
especi
kitten
increas
effect
overcrowd
fip
incid
particularli
evid
anim
shelter
loss
caus
fip
inevit
increas
shelter
overwhelm
cat
usual
kitten
season
decreas
overcrowd
control
longer
shelter
stay
compound
situat
k
hurley
uc
davi
unpublish
inform
loss
fip
also
proport
sever
kittenhood
diseas
includ
caus
herpesviru
caliciviru
chlamydophila
mycoplasma
dermatophyt
numer
bacteri
viral
fungal
protozo
parasit
skin
upper
respiratori
enter
infect
kitten
kept
crowd
catteri
shelter
larg
number
young
anim
suffer
greatli
concurr
diseas
diseas
stress
kitten
immun
system
caus
decreas
growth
rate
increas
suscept
diseas
gener
felv
infect
bane
mani
catteri
shelter
multicat
environ
past
singl
power
potenti
fip
cat
fortun
felv
infect
push
back
natur
western
countri
aggress
campaign
test
eradicationisol
shedder
vaccin
longer
problem
multicat
environ
genet
also
play
import
role
fip
genet
resistancesuscept
factor
also
affect
fip
incid
obvious
strongest
influenc
catteri
death
loss
fip
sometim
trace
certain
breed
breed
pair
produc
affect
kitten
avoid
tom
produc
litter
suffer
fip
especi
avoid
given
male
affect
far
litter
individu
queen
breed
practic
catteri
often
result
abund
younger
breed
anim
incid
fip
static
multicat
household
known
decreas
year
may
associ
age
resist
chronic
intermitt
fecv
shed
immun
sort
develop
period
mani
month
year
age
resist
period
time
seen
sever
chronic
type
infect
herpesviru
felin
caliciviru
felv
ringworm
catteri
shelter
keep
mainli
older
cat
much
less
infecti
diseas
problem
catteri
younger
breed
shelter
anim
practic
isol
queen
earli
wean
kitten
advoc
control
fip
catteri
wide
practic
catteri
kitten
infect
fecv
around
week
age
queen
isol
prior
parturit
kept
strict
quarantin
sourc
fecvexposur
remov
kitten
earliest
possibl
time
week
birth
kitten
maintain
thereaft
isol
possibl
prevent
kitten
becom
infect
fecv
henc
prevent
fip
howev
practic
work
best
small
catteri
requir
elabor
quarantin
facil
strict
control
exposur
gross
microscop
litter
dust
contain
high
level
viru
litter
dust
omnipres
easili
spread
air
cage
pan
accessori
cloth
therefor
strict
quarantin
involv
separ
quarter
care
giver
separ
litter
food
water
pan
separ
air
space
changeinchangeout
protect
cloth
includ
shoessho
coversboot
foot
bath
etc
isol
facil
consist
anoth
room
home
special
precaut
specif
design
isol
room
avail
altern
would
transfer
kitten
earli
wean
distant
facil
home
devoid
cat
problem
isol
pregnant
queen
earli
wean
program
sever
fold
first
level
quarantin
requir
prevent
contamin
requir
expens
facil
great
cost
oper
second
done
coronaviru
free
kitten
produc
infect
coronaviru
almost
assur
kitten
reintroduc
normal
environ
expect
carri
normal
activ
reloc
new
home
show
breed
howev
remain
one
advantag
success
isol
earli
wean
program
delay
infect
kitten
week
age
older
time
immun
system
began
attain
adult
level
activ
kitten
becom
resist
clinic
diseas
sort
includ
fip
catteri
undertak
isol
earli
wean
program
determin
whether
work
given
facil
level
husbandri
kitten
come
earli
wean
program
found
seroposit
week
age
andor
shed
fecv
fece
program
fail
given
cost
logist
problem
author
highli
recommend
isol
earli
wean
program
especi
larger
catteri
six
breed
cat
costeffect
mean
control
fip
loss
fivefold
elimin
overcrowd
possibl
maintain
six
breed
anim
maintain
larger
proport
older
cat
year
age
older
manag
fece
mouth
spread
properli
manag
litter
box
litter
replac
gross
microscop
spread
litter
litter
dust
highli
select
breed
program
produc
minimum
number
litter
control
genet
use
tom
minimum
produc
kitten
develop
fip
prefer
use
neither
tom
queen
produc
kitten
die
fip
step
far
effect
improperli
conduct
isol
earli
wean
program
easili
implement
immun
fipv
infect
fascin
topic
two
reason
first
appear
humor
immun
import
protect
may
actual
particip
diseas
process
second
protect
immun
appear
larg
cell
mediat
may
infect
premonit
type
third
type
strength
immun
appear
determin
form
fipv
infect
take
reason
assum
strong
humor
immun
weak
nonexist
cellular
immun
lead
effus
fip
humor
immun
intermedi
cellular
immun
manifest
noneffus
fip
humor
immun
strong
cellular
immun
prevent
diseas
although
mainli
work
hypothes
consider
evid
antibodi
fipv
antigen
particip
two
differ
immun
process
neither
correl
immun
first
process
arthustyp
hypersensit
reaction
center
small
venul
second
process
antibodymedi
enhanc
viral
uptak
replic
macrophag
three
compon
arthustyp
reaction
antigen
complement
antibodi
present
high
level
within
lesion
especi
cat
effus
fip
fig
arthu
reaction
character
vascul
edema
inflammatorycel
migrat
necrosi
antibodymedi
enhanc
diseas
first
describ
pedersen
boyl
confirm
weiss
scott
note
appear
antibodi
diseas
sign
alway
link
seroneg
cat
develop
earliest
sign
fip
within
day
experiment
infect
time
diseas
alway
coincid
appear
antibodi
healthi
fcov
antibodi
posit
ie
fecv
expos
cat
challengeexpos
fipv
fever
diseas
sign
occur
within
h
instead
usual
day
coronaviru
seroneg
cat
passiv
immun
fecv
induc
antibodi
form
serum
immunoglobulin
also
manifest
acceler
diseas
challengeexpos
fipv
phenomenon
antibodymedi
enhanc
later
confirm
involv
antibodi
specif
epitop
spike
protein
antibodi
also
function
neutral
antibodi
vitro
macrophag
infect
greatli
enhanc
vitro
addit
immun
serum
led
plausibl
theori
antibodi
complement
coat
viral
particl
taken
fc
receptor
macrophag
process
endocytosi
place
fipv
host
cell
choic
viru
spread
place
bodi
macrophag
migrat
antibodymedi
enhanc
macrophag
infect
appear
serotyp
specif
ie
antibodi
serotyp
ii
fipv
enhanc
macrophag
infect
serotyp
ii
fipv
antibodymedi
immunopathogenesi
effus
fip
role
macrophag
diseas
appear
similar
describ
dengu
hemorrhag
shock
syndrom
hallmark
dengu
hemorrhag
fever
effus
fip
arthustyp
reaction
viral
laden
macrophag
viral
particl
viral
protein
accumul
around
small
venul
local
sourc
antigen
well
antigen
blood
react
complement
form
immun
complex
turn
immun
complex
deposit
around
small
venul
trigger
releas
specif
macrophag
factor
caus
tissu
damag
paltrinieri
et
al
also
demonstr
fip
lesion
contain
mani
virusinfect
macrophag
extracellular
viral
antigen
also
detect
foci
along
necrosi
necrosi
one
hallmark
arthustyp
vascul
although
great
deal
made
antibodymedi
enhanc
fip
may
import
natur
laboratori
furthermor
phenomenon
describ
mainli
certain
fcov
isol
fecvucd
unknown
fecv
strain
fecvrm
observ
phenomenon
field
strain
fipv
fecvrm
nc
pedersen
uc
davi
person
observ
gener
appear
virul
fipv
isol
like
respond
antibodi
enhanc
antibodi
spike
protein
may
also
alway
harm
western
blot
antibodi
respons
three
major
structur
protein
measur
cat
natur
infect
fecv
compar
diseas
outcom
ie
recoveri
chronic
asymptomat
carrier
state
fip
cat
chronic
asymptomat
infect
develop
spike
glycoprotein
rel
antim
glycoprotein
antibodi
respons
least
higher
cat
chronic
asymptomat
symptomat
infect
conclud
antibodi
spike
protein
favor
clearanc
viru
natur
infect
risk
factor
establish
chronic
infect
although
mani
studi
support
special
role
antibodi
fip
form
take
rel
mechanist
studi
actual
bcell
respons
fip
takano
et
al
demonstr
five
factor
associ
bcell
activ
fip
found
ratio
peripher
blood
sig
bcell
higher
cat
fip
spf
cat
albumintoglobulin
ratio
neg
correl
ratio
peripher
blood
sig
bcell
cell
strongli
express
mrna
plasma
cell
master
gene
blymphocyteinduc
matur
protein
increas
peripher
blood
cat
fip
mrna
express
bcell
differentiationsurviv
factor
ligand
bcellactiv
factor
belong
tnf
famili
baff
enhanc
macrophag
cat
fip
mrna
bcell
differentiationsurviv
factor
overexpress
antibodydepend
enhanc
ade
induc
macrophag
scenario
virusinfect
macrophag
overproduc
bcell
differentiationsurviv
factor
turn
act
promot
bcell
differenti
plasma
cell
group
also
investig
key
step
ade
fip
involv
viru
receptor
requir
acidif
endosom
cellular
invas
conclud
aminiopeptidats
n
requir
antibodi
enhanc
howev
acidif
endosom
necessari
cellular
invas
fipv
regardless
presenc
absenc
antibodi
humor
immun
protect
cat
virul
strain
fipv
natur
fipv
immun
postul
immun
fipv
larg
cell
mediat
reason
assumpt
includ
follow
noneffus
form
fip
resembl
tuberculosi
deep
mycot
infect
human
anim
immun
infect
known
involv
mainli
cellular
mechan
lesion
dri
fip
resembl
type
iv
hypersensit
reaction
central
macrophag
contain
rel
small
amount
viru
surround
dens
infiltr
plasma
cell
lymphocyt
pyogranuloma
wet
fip
aggreg
macrophag
stuf
viru
surround
mainli
neutrophil
edema
clinic
incid
fip
increas
greatli
concurr
felv
infect
felv
infect
potent
suppress
cellular
immun
tcell
mediat
humor
immun
immun
fip
transfer
passiv
hyperimmun
serum
regardless
whether
serum
taken
fecvinfect
cat
cat
surviv
fipv
challeng
delayedtyp
hypersensit
reaction
fip
antigen
evok
conjunctiva
fip
immun
cat
peripher
blood
lymphocyt
recov
cat
respond
vitro
fipv
antigen
cat
known
carri
fipv
latent
sequest
infect
infect
reactiv
infect
carrier
felv
methylprednisolon
acet
carrier
state
latter
type
known
exist
infect
like
tuberculosi
blastomycosi
histoplasmosi
coccidoidomycosi
immun
sustain
situat
persist
small
number
organ
mesenter
bronchial
lymph
node
type
immun
call
premonit
infect
immun
persist
long
intracellular
pathogen
persist
reactivat
form
phenomenon
may
observ
cat
immun
virul
modifi
live
fipv
immun
cat
show
outward
sign
diseas
challengeexpos
virul
fipv
month
later
residu
lesion
fip
found
histolog
stoddart
et
al
studi
viru
shed
immun
respons
eight
spf
cat
inocul
oral
intraperiton
cell
cultureadapt
fipv
viru
recov
fece
oropharyng
swab
approxim
week
inocul
clinic
sign
diseas
develop
eight
cat
show
profound
suppress
peripher
blood
lymphocyt
blastogen
respons
con
recov
preinocul
level
two
cat
one
surviv
con
reactiv
cat
also
lymphocyt
blastogen
respons
fipv
antigen
day
infect
greatest
respons
survivor
cat
die
fip
day
develop
respons
fipv
antigen
antibodi
titer
measur
immunofluoresc
viru
neutral
rose
rapidli
high
level
cat
regardless
rout
inocul
studi
also
support
role
cell
mediat
immun
rather
antibodi
fip
degrootmijn
et
al
put
forward
unifi
concept
tcell
respons
fip
postul
virusinduc
tcell
deplet
antivir
tcell
respons
oppos
forc
efficaci
earli
tcell
respons
critic
determin
outcom
infect
viru
win
fip
result
host
win
diseas
develop
observ
consist
rise
level
viral
rna
blood
cat
endstag
fip
indic
fatal
diseas
directli
relat
loss
immun
control
uncheck
viral
replic
paltrinieri
et
al
analyz
lymphoct
subset
marker
flow
cytometri
cat
recent
infect
fecv
develop
fip
transient
increas
tcell
fecvinfect
cat
high
preval
fip
moder
persist
decreas
tcell
subset
cat
fip
sever
decreas
lymphocyt
subset
cours
argu
chicken
egg
manner
level
viremia
determin
outcom
addit
studi
support
role
cellular
immun
possibl
premonit
type
fip
resist
suscept
possibl
immun
cat
fipv
start
small
subinfecti
dose
viru
gradual
increas
dose
time
cat
immun
manner
eventu
resist
infect
dosag
viru
would
lethal
cat
howev
immun
overcom
time
larg
amount
virul
viru
moreov
one
cat
immun
manner
repeatedli
immun
cat
infecti
dose
virul
fipv
year
eventu
succumb
noneffus
fip
nc
pedersen
uc
davi
person
observ
author
also
observ
natur
infect
cat
respond
nonspecif
treatment
went
sustain
remiss
redevelop
fip
year
later
die
premonit
immun
may
also
pass
fipv
immun
queen
kitten
kitten
born
queen
frequent
show
typic
antibodi
pattern
matern
immunoglobulin
transfer
matern
infect
matern
antibodi
fcov
note
kitten
blood
shortli
birth
declin
next
sever
week
spontan
increas
first
peak
antibodi
correspond
acquisit
loss
matern
antibodi
second
peak
result
activ
immun
respons
kitten
five
six
kitten
challeng
fipv
week
age
resist
challengeexposur
surviv
kitten
succumb
acceler
form
effus
fip
infect
week
age
fip
reactiv
secondari
felv
infect
almost
cat
within
first
month
resist
diseas
primari
fipv
infect
month
situat
resembl
seen
latent
felv
infect
latenc
felv
infect
mere
extens
recoveri
process
usual
resolv
within
month
disappear
viremia
appear
characterist
mani
infecti
diseas
cellular
immun
import
recoveri
longer
period
recoveri
difficult
demonstr
persist
agent
immun
mani
infect
includ
fip
must
slow
ongo
process
take
week
month
year
individu
agent
may
persist
lifetim
sever
studi
fip
attempt
link
occurr
diseas
certain
profil
cytokin
express
kiss
et
al
small
pilot
type
studi
suggest
cat
develop
either
wet
dri
fip
experiment
infect
express
high
level
mrna
tnfa
low
level
mrna
interferon
gamma
cat
resist
diseas
opposit
respons
neg
role
tnfa
fip
support
studi
link
tnfa
releas
macrophag
apoptosi
tcell
result
lymphopenia
tnfa
may
also
upregul
felin
aminopeptidasen
receptor
felin
macrophag
make
suscept
infect
similar
type
studi
wet
fip
measur
cellular
express
interferon
gamma
variou
type
lesion
inflammatori
cell
cell
within
lesion
includ
bcell
plasma
cell
well
tcell
howev
macrophag
seem
key
cellular
element
wet
dri
form
fip
interferongamma
express
upregul
within
macrophag
inflammatori
lesion
suggest
local
activ
dean
et
al
attempt
correl
histolog
chang
lymphoid
tissu
lymphoid
hyperplasia
lymphoid
deplet
histiocytosi
granuloma
format
cytokin
express
viral
rna
found
mediastin
lymph
node
spleen
mesenter
lymph
node
compar
poplit
lymph
node
cervic
lymph
node
femor
bone
marrow
tissu
posit
viru
replic
also
demonstr
lymphoid
deplet
affect
tissu
lower
level
mrna
higher
level
mrna
differ
ifng
tnfa
mrna
tnfa
protein
express
greater
affect
tissu
associ
shift
sourc
tnfa
macrophag
lymphocyt
therefor
fipv
replic
lymphocyt
deplet
tissu
alter
cytokin
transcript
translat
coloc
tissu
possibl
role
tnfa
previous
describ
fipvinduc
lymphocyt
apoptosi
also
suggest
cytokin
respons
compar
cat
neurolog
focal
gener
fip
rational
local
neurolog
diseas
homogen
ie
stereotyp
gener
fip
tnfa
macrophag
inhibitori
protein
mip
rant
show
upregul
brain
control
cat
moder
upregul
cat
neurolog
fip
high
upregul
cat
gener
fip
ifng
gene
transcript
upregul
cat
gener
fip
slightli
downregul
cat
neurolog
fip
varianc
high
cat
gener
fip
much
lower
cat
neurolog
fip
larg
compon
varianc
account
rant
level
anoth
cytokin
studi
group
kitten
preimmun
two
recombin
fipv
spike
protein
challeng
intranas
kitten
develop
confirm
fip
recombin
protein
induc
littl
specif
antibodi
respons
prior
challeng
fail
enhanc
inhibit
cours
diseas
compar
control
mitogen
stimul
pbmc
collect
week
show
small
increas
express
interferongamma
mrna
correl
initi
febril
respons
thereaft
express
mrna
remain
unalt
sign
fip
develop
point
mrna
level
interferon
gamma
markedli
depress
kipar
et
al
compar
cytokin
mrna
level
variou
lymphoid
tissu
cat
exposur
fecv
without
develop
fip
note
lymphoid
tissu
normal
hyperplast
healthi
fecv
expos
cat
band
tcell
deplet
present
cat
develop
fip
therefor
compar
function
chang
bone
marrow
mesenter
lymph
node
healthi
fecv
expos
cat
cat
develop
fip
fecvinfect
cat
develop
fip
exhibit
significantli
higher
level
spleen
significantli
lower
level
gand
mcsf
mesenter
lymph
node
contrast
level
significantli
lower
lymphat
tissu
cat
fip
compar
fecvinfect
cat
without
fip
cat
fip
significantli
higher
level
lower
tnfa
level
mesenter
lymph
node
lower
mcsf
level
spleen
conclud
fecvexpos
cat
develop
fip
abl
make
protect
immun
avoid
excess
macrophag
activ
fip
possibl
upregul
develop
fip
may
also
associ
lack
product
inhibit
effect
cellular
immun
respons
allow
monocytemacrophag
activ
rapid
activ
mapk
pathway
demonstr
fipv
infect
blood
mononuclear
cell
spf
cat
mapk
activ
led
product
proinflammatori
cytokin
tnfa
tnfa
product
inhibit
pyridinyl
imidazol
inhibitor
recent
studi
also
measur
concentr
interferon
gamma
fecv
expos
cat
develop
fip
found
healthi
fecvexpos
cat
live
catteri
high
incid
fip
highest
serum
interferongamma
concentr
howev
serum
concentr
interferon
gamma
significantli
differ
cat
develop
fip
healthi
fecvexpos
cat
catteri
low
preval
fip
concentr
interferon
gamma
significantli
higher
effus
serum
cat
fip
probabl
due
interferongamma
product
within
lesion
similar
studi
measur
cytokin
mrna
compar
spf
cat
cytokin
product
upregul
nonsymptomat
fecv
expos
cat
catteri
fip
appear
fip
catteri
associ
increas
express
cytokin
particular
increas
product
interferon
gamma
suggest
cytokin
help
protect
fip
hypothesi
support
low
level
interferon
gamma
record
blood
cat
fip
compel
corrobor
evid
role
interferon
gamma
protect
fip
cat
come
interferongamma
gene
knockout
mice
kyuwa
et
al
describ
granulomat
periton
pleuriti
virtual
ident
fip
knockout
mice
infect
laboratori
strain
mous
hepat
viru
murin
coronaviru
ident
diseas
observ
strain
knockout
mice
natur
expos
field
strain
murin
coronaviru
genet
host
factor
appear
strong
influenc
resist
suscept
fipv
natur
studi
fip
number
purebr
persian
catteri
show
suscept
herit
account
diseas
incid
addi
et
al
attempt
link
diseas
suscept
certain
allel
within
drb
gene
felin
mhc
felin
leucocyt
antigen
fla
individu
cat
shown
two
six
fladrb
allel
specif
allel
appear
associ
either
develop
fip
resist
fcov
gener
fecv
carrier
statu
howev
pilot
studi
lack
number
cat
breadth
studi
conclud
genet
differ
within
fla
complex
involv
fip
kipar
et
al
report
cat
develop
fip
natur
fcovexposur
significantli
higher
rate
viral
replic
reduc
capac
viru
clearanc
cat
expos
develop
fip
suggest
host
factor
felv
potent
potenti
fip
thirtyf
case
fip
observ
among
convent
nonspf
except
felv
cat
experiment
infect
felv
natur
contact
experiment
infect
death
due
fip
occur
within
rel
short
time
becam
felv
virem
one
cat
similar
cohort
nonfelv
expos
cat
die
fip
antibodi
titer
fipv
began
rais
progress
cat
becam
virem
felv
reach
high
level
prior
death
fip
anim
public
health
consider
fipv
natur
occur
infect
domest
wild
felida
peopl
host
viru
dog
swine
experiment
infect
fipv
one
first
commerci
ccv
vaccin
dog
may
actual
consist
fipv
hundr
dog
die
sever
neurolog
pancreat
diseas
recal
mild
moder
sever
tgelik
syndrom
occur
babi
pig
howev
doubt
fipv
caus
natur
occur
diseas
speci
comparison
felin
coronavirus
particular
fipv
human
sar
coronaviru
noteworthi
coronaviru
found
palm
civet
cat
mustelida
felida
homolog
human
sar
coronaviru
appar
well
adapt
host
speci
howev
viru
abl
genetici
adapt
human
effect
potenti
devast
coronaviru
homolog
sar
coronaviru
exist
horsesho
bat
suggest
coronaviru
adapt
speci
speci
rel
short
long
period
time
abil
mutat
recombin
insertiondelet
mutat
singl
nucleotid
polymorph
chang
host
speci
reminisc
close
relationship
canin
porcin
felin
coronavirus
human
sar
coronaviru
also
interest
nucleotid
delet
one
accessori
gene
orf
present
host
speci
damag
mutat
within
accessori
gene
fecv
orf
known
associ
fecv
fipv
mutat
cat
particip
host
viru
factor
import
develop
sar
rat
model
increas
virul
old
compar
young
rat
human
host
viru
factor
involv
fip
cat
diseas
close
resembl
fip
cat
caus
speci
relat
coronavirus
describ
ferret
mice
